site stats

Cytokinetics board of directors

WebCYTOKINETICS, INCORPORATED 2004 EQUITY INCENTIVE PLAN, AS AMENDED (As amended by the Board of Directors on February 6, 2013; Stockholder approval May 22, 2013; updated following reverse stock split June 25, 2013) from Cytokinetics, Incorporated filed with the Securities and Exchange Commission. WebMar 7, 2015 · Senior Medical Director, Medical Affairs, Cardiovascular Cytokinetics, Inc. Heart Failure focus Learn more about Robb Kociol's work experience, education, connections & more by visiting their ...

Cytokinetics Incorporated : 2024 Notice of Annual Meeting and …

WebApr 17, 2024 · Cytokinetics Names Muna Bhanji to Board of Directors. SOUTH SAN FRANCISCO, Calif., Feb. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Muna Bhanji has been appointed to the company’s Board of Directors. Ms. Bhanji brings more than 30 years of strategic and … WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced changes to its Board of Directors. L. Patrick Gage, Ph.D., Chairman... ariana lira https://pipermina.com

Cytokinetics on LinkedIn: Cytokinetics Announces Changes to …

WebFeb 20, 2009 · Dr. Henderson joins the Cytokinetics Board of Directors with over 30 years of experience in the life science industry. Since December 2000, Dr. Henderson has served as a consultant to the pharmaceutical industry as president of Futurepharm LLC. Until his retirement in December 2000, Dr. Henderson was an employee of Pfizer Inc. for over 25 … WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced changes to its Board of Directors. L. Patrick Gage, Ph.D., Chairman of the Board of Directors since March 2010, will resign from the Board effective April 8, 2024. WebFeb 11, 2011 · On behalf of Cytokinetics' management and our Board, we are grateful for his strategic insights and professional oversight that have contributed to the company's … balandreaud

Cytokinetics Announces Changes to Board of Directors - Yahoo …

Category:Cytokinetics Names Robert Califf, M.D., to Board of Directors

Tags:Cytokinetics board of directors

Cytokinetics board of directors

Muna Bhanji - Cytokinetics

WebFeb 3, 2024 · Cytokinetics' insider roster includes Robert Blum (CEO), Santo Costa (Director), David Cragg (Insider), L. Gage (Director), John Henderson (Director), Ching Jaw (CFO), Edward Kaye (Director), Fady Malik (EVP), B. Parshall (Director), Mark Schlossberg (SVP), Sandford Smith (Director), and Wendall Wierenga (Director). WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.

Cytokinetics board of directors

Did you know?

WebApr 8, 2024 · SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced changes to its Board of Directors. … WebWe are pleased to welcome Dr. Robert Harrington to our Board of Directors. He brings years of expertise and experience as a practicing cardiologist, professor…

WebNov 20, 2024 · SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Nancy Wysenski has been appointed to the company’s Board of ... WebJul 1, 2024 · Cytokinetics assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact:...

WebFeb 1, 2024 · The grant was previously approved by the Compensation and Talent Committee of Cytokinetics’ Board of Directors under the company’s Amended and Restated 2004 Equity Incentive Plan ... WebMichael Schmertzler has served as a member of PTC's board of directors since August 2001 and as the Chairman of our board of directors since November 2004. From 2008 to 2012, Michael Schmertzler served as Chief Executive Officer and a director of Kolltan Pharmaceuticals, Inc., a biotechnology company. Since 2001, Michael Schmertzler has.

WebMuna Bhanji has served as a member of our Board of Directors since February 2024. Her prior experience includes a 30+ year tenure at Merck, during which she held a number of …

ariana ledyWebCytokinetics Announces Addition to Board of Directors Company Announces Appointment of Denise Gilbert, Ph.D. SOUTH SAN FRANCISCO, CA, May 16, 2008 (MARKET … balan dr. bad aiblingWebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ... balandra vertical guadalajara